Genetics

ASBrS Statement: All Breast Cancer Patients Should Receive Multigene Panel Tests, Surgeon Group Says

“Genetic testing should be made available to all patients with a personal history of breast cancer,” the ASBrS stated in an updated consensus statement. “If genetic testing is performed, such testing should include BRCA1/BRCA2 and PALB2, with other genes as appropriate for the clinical scenario and family history.”

NEW YORK (GenomeWeb) | FEB 15, 2019 – The American Society of Breast Surgeons recommended that individuals with breast cancer receive testing on multigene panels to assess their hereditary risk for cancer.

READ FULL ASBrS CONSENSUS STATEMENT …

READ FULL STORY (GenomeWeb) …

SOURCE: https://www.genomeweb.com/molecular-diagnostics/all-breast-cancer-patients-should-receive-multigene-panel-tests-surgeon-group?utm_source=Sailthru&utm_medium=email&utm_campaign=GWDN%20Fri%20PM%202019-02-15&utm_term=GW%20Daily%20News%20Bulletin#.XGcpOKB7l7M

Categories: Genetics